General practitioners' views on the influence of cost on the prescribing of asthma preventer medicines: a qualitative study

Australian Health Review : a Publication of the Australian Hospital Association
Jacqueline TudballNick Zwar

Abstract

Objective Out-of-pocket costs strongly affect patient adherence with medicines. For asthma, guidelines recommend that most patients should be prescribed regular low-dose inhaled corticosteroids (ICS) alone, but in Australia most are prescribed combination ICS-long-acting β2-agonists (LABA), which cost more to patients and government. The present qualitative study among general practitioners (GPs) explored the acceptability, and likely effect on prescribing, of lower patient copayments for ICS alone. Methods Semistructured telephone interviews were conducted with 15 GPs from the greater Sydney area; the interviews were transcribed and thematically analysed. Results GPs reported that their main criteria for selecting medicines were appropriateness and effectiveness. They did not usually discuss costs with patients, had low awareness of out-of-pocket costs and considered that these were seldom prohibitive for asthma patients. GPs strongly believed that patient care should not be compromised to reduce cost to government. They favoured ICS-LABA combinations over ICS alone because they perceived that ICS-LABA combinations enhanced adherence and reduced costs for patients. GPs did not consider that lower patient copayments for ICS alo...Continue Reading

References

Aug 3, 2000·The New England Journal of Medicine·S SuissaB Cai
Sep 26, 2002·Social Science & Medicine·W N KasjeF M Haaijer-Ruskamp
Feb 10, 2004·The Journal of Allergy and Clinical Immunology·Stuart W StoloffJacqueline R Carranza Rosenzweig
Nov 6, 2004·Australian Health Review : a Publication of the Australian Hospital Association·Lloyd Sansom
Sep 6, 2005·Respiratory Medicine·D A StempelA P Legorreta
Apr 6, 2007·Journal of General Internal Medicine·Becky A BriesacherStephen B Soumerai
Oct 12, 2007·Qualitative Health Research·Jeanette Hewitt
Jan 24, 2008·Journal of Clinical Pharmacy and Therapeutics·A Mason
May 1, 2008·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Gene L ColiceCorrine Brewster
Oct 24, 2008·Pharmacoepidemiology and Drug Safety·Anna HyndJames Semmens
Sep 23, 2009·The Medical Journal of Australia·Rosario D AmponGuy B Marks
Mar 6, 2010·Journal of Health Services Research & Policy·Anna KempJames Semmens
Sep 29, 2011·Patient Preference and Adherence·John D PietteColleen A McHorney
Aug 31, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Astrid Kiil, Kurt Houlberg
Oct 1, 2014·JAMA : the Journal of the American Medical Association·Tammy C HoffmannChris Del Mar
Oct 22, 2014·BMC Health Services Research·Ágnes Lublóy
May 15, 2015·The Medical Journal of Australia·Helen K ReddelMatthew J Peters
Mar 8, 2016·The New England Journal of Medicine·David A StempelUNKNOWN AUSTRI Investigators
Sep 1, 2016·The New England Journal of Medicine·Stephen P PetersUbaldo J Martin
Apr 20, 2018·Australian Prescriber·Helen K ReddelNicholas J Zwar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.